$122.19
6.435.55%
Last update: Nov 9, 5:03 PM
Hinge Health Inc
HNGENYSE
Hinge Health rose 175.8% from $44.30 to a 1-year high of $122.19, ahead of the S&P 500's +10.5%. Its worst day was Mar 27 (−9.8%), and its low came Feb 6 at $31.17.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Hinge Health shares rose 8.6%, while the S&P 500 rose 0.4%.
+8.6% · S&P 500 +0.4%
EPS of $0.49 beat the $0.27 estimate on $170.7M revenue (est. $157.0M); Q1 revenue guidance of $171.0M–$173.0M against the $159.9M consensus.
Story events cover the past 12 months · Times ET
+17.3%, the year's best day · S&P 500 0.0%
Hinge Health shares fell 9.8%, while the S&P 500 fell 1.7%.
−9.8%, the year's worst day · S&P 500 −1.7%
EPS of $0.45 beat the $0.34 estimate on $182.3M revenue (est. $172.2M); FY revenue guidance of $798.0M–$804.0M against the $741.0M consensus.
+10.2% · S&P 500 +1.4%
Hinge Health shares rose 8.4%, while the S&P 500 rose 0.3%.
+8.4% · S&P 500 +0.3%
EPS of $0.59 beat the $0.55 estimate on $212.8M revenue (est. $201.1M); FY revenue guidance of $856.0M–$860.0M against the $822.3M consensus.
+1.7% · S&P 500 −0.2%
EPS of $0.66 beat the $0.53 estimate on $235.0M revenue (est. $224.9M); FY revenue guidance of $879.0M–$881.0M against the $858.5M consensus.
+1.2% · S&P 500 +0.3%
Where it ended: a 1-year high close of $122.19 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 9, 2027 (EPS est. $0.54, revenue est. $249.5M).
Nothing in the past 12 months.
All HNGE dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for HNGE and SPY from Benzinga historical bars. Not investment advice.
